LampropoulouD. I.; BalaV. M.; ZervaE.; PliakouE.; FilippouD.; GazouliM.; AravantinosG. The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection. The Journal of Infection in Developing Countries, v. 16, n. 01, p. 101-111, 31 Jan. 2022.